Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Arzneimittelforschung

Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,401 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias

Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549 · see citing works

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation

Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759 · see citing works

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

Heber, D., Yip, I., Ashley, J. M., Elashoff, D. A., Elashoff, R. M., & Go, V. L. W. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.2.231 · Cited by 499 · see citing works

Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo

Saks, V. A., Veksler, V., Kuznetsov, A. V., Kay, L., Sikk, P., Tiivel, T., Tranqui, L., Olivares, J., Winkler, K., Wiedemann, F. R., et al. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5653-4_7 · Cited by 361 · see citing works

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315 · see citing works

Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vitro

Veksler, V., Kuznetsov, A. V., Kay, L., Sikk, P., Tiivel, T., Tranqui, L., Olivares, J., Winkler, K., Wiedemann, F. R., & Kunz, W. S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006834912257 · Cited by 308 · see citing works

A DOSE-RESPONSE STUDY

Skripitz, R., Andreassen, T. T., & Aspenberg, P. (2000) · Cited by 284 · see citing works

Toxicity of statins on rat skeletal muscle mitochondria

Kaufmann, P., Török, M., Zahno, A., Waldhauser, K. M., Brecht, K., & Krähenbühl, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6235-z · Cited by 263 · see citing works

Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent

Gouni‐Berthold, I., & Berthold, H. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119997 · Cited by 250 · see citing works

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.

Liu, J., Zhang, J., Shi, Y. P., Grimsgaard, S., Alræk, T., & Fønnebø, V. M. (2006) · Chinese Medicine · doi:10.1186/1749-8546-1-4 · Cited by 236 · see citing works

Statin-induced myopathies

Tomaszewski, M., Stępień, K. M., Tomaszewska, J., & Czuczwar, S. J. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70601-6 · Cited by 220 · see citing works

New insights into mechanisms of statin-associated myotoxicity

Sirvent, P., Mercier, J. G., & Lacampagne, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.010 · Cited by 190 · see citing works

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference

Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., & Pope, J. E. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.05.007 · Cited by 184 · see citing works

Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia

Berthold, H. K., Unverdorben, S., Degenhardt, R., Bulitta, M., & Gouni‐Berthold, I. (2006) · JAMA · doi:10.1001/jama.295.19.2262 · Cited by 167 · see citing works

Efficacy of Artichoke Dry Extract in Patients with Hyperlipoproteinemia

Englisch, W., Beckers, C., Unkauf, M., Ruepp, M., & Zinserling, V. A. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300196 · Cited by 131 · see citing works

Simvastatin induces impairment in skeletal muscle while heart is protected

Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.108 · Cited by 116 · see citing works

Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes

Kwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.449 · Cited by 114 · see citing works

Statin-Induced Myopathies

Amato, A. (2006) · Journal watch · doi:10.1056/jn200606220000001 · Cited by 104 · see citing works

Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.

Pons, P. G., Rodriguez, M., Robaina, C., et al. (1994) · PubMed · Cited by 91 · see citing works

Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins

Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90 · see citing works

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia

Hunninghake, D. B., Mellies, M. J., Goldberg, A. C., Kuo, P. T., Kostis, J. B., Schrott, H. G., Insull, W., & Pan, H. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90114-x · Cited by 86 · see citing works

Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress

Bouitbir, J., Charles, A.-L., Rasseneur, L., Dufour, S., Piquard, F., Geny, B., & Zoll, J. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00107.2011 · Cited by 86 · see citing works

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia

Hunninghake, D. B., Knopp, R. H., Schonfeld, G., Goldberg, A. C., Brown, W. V., Schaefer, E. J., Margolis, S., Dobs, A. S., Mellies, M. J., Insull, W., et al. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90185-l · Cited by 77 · see citing works

Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia.

Klimek, M., Wang, S., & Ogunkanmi, A. (2009) · Europe PMC (PubMed Central) · Cited by 76 · see citing works

Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: A dose–response effect dependent on endothelial nitric oxide synthase

Chen, H., Ren, J., Xing, Y. T., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.044 · Cited by 63 · see citing works

Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia

Saitō, Y., Goto, Y., Dane, A. L., Strutt, K., & Raza, A. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.329 · Cited by 53 · see citing works

LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia

Ogier, N., Amiot, M.-J., Georgé, S., Maillot, M., Mallmann, C., Maraninchi, M., Morange, S., Lescuyer, J.-F., Peltier, S. L., & Cardinault, N. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0357-x · Cited by 49 · see citing works

Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.

Castaño, G., Fernández, L., Más, R., et al. (2002) · PubMed · Cited by 25 · see citing works

Efficacy of a low dose‐range of fluvastatin (XU 62‐320) in the treatment of primary hypercholesterolaemia. A dose‐response study in 431 patients. The French‐Dutch Fluvastatin Study Group.

JACOTOT, B., Banga, J., Pfister, P., et al. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04350.x · Cited by 24 · see citing works

Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia

Crouse, J. R., Lukacsko, P., & Niecestro, R. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02207-x · Cited by 7 · see citing works

[Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].

Jiang, F., Sun, L., & Yang, J. (2011) · PubMed · Cited by 5 · see citing works

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281 · see citing works

A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia

Li, Y., Jiang, L., Jia, Z., Xin, W., Yang, S., Yang, Q., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098611 · Cited by 124 · see citing works

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00955-y · Cited by 110 · see citing works

Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial

Cicero, A. F. G., Colletti, A., Fogacci, F., Bove, M., Rosticci, M., & Borghi, C. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0163-2 · Cited by 35 · see citing works

Red Yeast Rice Preparations: Are They Suitable Substitutions for Statins?

Dujovne, C. A. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.05.013 · Cited by 29 · see citing works

Is red yeast rice a safe and effective alternative to statin drugs for lowering cholesterol?

Andersen, A., & Kraus, C. K. (2013) · Evidence-Based Practice · doi:10.1097/01.ebp.0000540520.28085.59

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review

Cicero, A. F. G., Fogacci, F., Stoian, A. P., & Toth, P. P. (2023) · Nutrients · doi:10.3390/nu15102288 · Cited by 47 · see citing works

Cholesterol measurement and current guidelines

Soška, V. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.007 · Cited by 3 · see citing works

Utilization of calculated low density lipoprotein cholesterol and measured low density lipoprotein cholesterol in Siriraj Hospital.

Wongtiraporn, W., Wattanamongkonsil, L., Kiartivich, S., et al. (2006) · PubMed